Advertisement
Research Article| Volume 20, 101241, March 2023

Download started.

Ok

Prevalence and predictive determinants of adherence to vaccination against COVID-19 among mothers who gave birth in the last two years in Morocco

  • Fatima Zohra Benayad
    Correspondence
    Corresponding author. Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy of Rabat, Mohammed V University of Rabat, Morocco.
    Affiliations
    Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy of Rabat, Mohammed V University of Rabat, Morocco

    Laboratory of Social Medicine (Public Health, Hygiene and Preventive Medicine), Department of Epidemiology and Public Health, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University of Rabat, Morocco
    Search for articles by this author
  • Rachid Razine
    Affiliations
    Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy of Rabat, Mohammed V University of Rabat, Morocco

    Laboratory of Social Medicine (Public Health, Hygiene and Preventive Medicine), Department of Epidemiology and Public Health, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University of Rabat, Morocco
    Search for articles by this author
  • Abbas Ermilo Haroun
    Affiliations
    Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy of Rabat, Mohammed V University of Rabat, Morocco

    Laboratory of Social Medicine (Public Health, Hygiene and Preventive Medicine), Department of Epidemiology and Public Health, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University of Rabat, Morocco
    Search for articles by this author
  • Ahmed Oubaasri
    Affiliations
    Laboratory of Social Medicine (Public Health, Hygiene and Preventive Medicine), Department of Epidemiology and Public Health, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University of Rabat, Morocco

    Higher Institutes of Nursing Professions and Health Techniques, Guelmim, Morocco
    Search for articles by this author
  • Elmostafa El Fahim
    Affiliations
    Molecular Biology and Functional Genomics Platform, National Center for Scientific and Technical Research (CNRST), Rabat, Morocco

    Neuroscience and Neurogenetics Research Team, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco
    Search for articles by this author
  • Redouane Abouqal
    Affiliations
    Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy of Rabat, Mohammed V University of Rabat, Morocco

    Laboratory of Social Medicine (Public Health, Hygiene and Preventive Medicine), Department of Epidemiology and Public Health, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University of Rabat, Morocco
    Search for articles by this author
  • Majdouline Obtel
    Affiliations
    Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy of Rabat, Mohammed V University of Rabat, Morocco

    Laboratory of Social Medicine (Public Health, Hygiene and Preventive Medicine), Department of Epidemiology and Public Health, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University of Rabat, Morocco
    Search for articles by this author
Open AccessPublished:January 28, 2023DOI:https://doi.org/10.1016/j.cegh.2023.101241

      Abstract

      Background and aim

      Vaccination against COVID-19 was one of the most important resolute to stop the spread of the pandemic; however, its acceptance was controversial especially by pregnant and lactating women. This study aims to assess the prevalence of vaccination among participants as well as to explore the determinants of reluctance or adherence to vaccination among this population, and to investigate the intention towards vaccination among the unvaccinated.

      Method

      This is a cross-sectional study conducted among mothers (n = 458) residing in the prefecture of Skhirat-Temara in Morocco, and who have children aged between one month to 2 years, the survey was conducted on the basis of a semi-structured questionnaire.

      Result

      The prevalence of vaccination among the participants was 61.8%, although they were all vaccinated after their delivery. Among the unvaccinated, 64% wanted to be vaccinated either because they believed the vaccines were useful or because they wanted to get the vaccine pass, while 36% absolutely refused to be vaccinated due to lack of sufficient information on the efficacy and safety of new vaccines against COVID-19. The age of the last child (p < 0.001) and no gestational diabetes during pregnancy (p = 0.016) were found to be positive predictors of vaccination adherence; however, the average or the high monthly income (p = 0.003) and the lack of medical coverage (p = 0.046) were predictive factors limiting adherence to vaccination.

      Conclusion

      The results of this study suggest that public health decision-makers need to increase awareness of the benefits of vaccination and to address the economic and social factors limiting access to COVID-19 vaccination.

      Keywords

      1. Introduction

      Since December 2019, the new corona virus disease (COVID-19) has rapidly invaded the world and caused serious respiratory complications and deaths. Consequently, this pandemic has weighed heavily on the health systems of nations on the one hand, and on the economies and lives of individuals and communities on the other hand especially with the recurrent appearance of variants of the virus in the absence of an effective treatment that could eradicate the disease. This crisis situation has pushed the rich countries to compete for the rapid invention of vaccines against COVID-19 to be able to stop the pandemic. Hence, taking up the challenge to develop new vaccines in a limited time through important investments in the pharmaceutical industry and the clinical trials that reached billions of dollars.
      • Chakraborty C.
      • Sharma A.R.
      • Bhattacharya M.
      • Lee S.-S.
      • Agoramoorthy G.
      • et al.
      COVID-19 vaccine: challenges in developing countries and India's initiatives.
      Meanwhile, the vaccination against the corona virus was subject to great controversy at the international level questioning the effectiveness, the safety, and the security of the new quickly invented vaccines.
      • Al-Qerem W.A.
      • Jarab A.S.
      • et al.
      COVID-19 vaccination acceptance and its associated factors among a middle eastern population.
      Indeed, low acceptance rates of corona virus vaccination have been recorded in the Middle East, Russia, Africa and in several European countries such as Italy and France.
      • Sallam M.
      COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates.
      Morocco was among the first countries to provide vaccination for its citizens, prioritizing at the outset in accordance with the recommendations of the World Health Organization (WHO). The prioritized segments included health professionals, people with strategic functions, the elderly, people with comorbidities, and those suffering from chronic diseases.
      OPSFPLIMCOVID-19210008_fre.pdf ». Consulté le: 12 avril 2022. [En ligne]. Disponible sur.
      Currently, Morocco has expanded the population eligible for vaccination against the corona virus to include pregnant women in their second trimester and those who are breastfeeding. This decision was taken in order to prevent and avoid the risks of pre-eclampsia, abortion, premature delivery, induced fetal death, hospitalization, and even intensive care unit services in the event that women contract the virus during their pregnancy.
      • Garg I.
      • Shekhar R.
      • Sheikh A.B.
      • Pal S.
      • et al.
      COVID-19 vaccine in pregnant and lactating women: a review of existing evidence and practice guidelines.
      The vaccination of this vulnerable category of the population against the corona virus was not addressed during the launch of the vaccination campaigns for reasons related to the safety, efficacy, and harmlessness of the new vaccines as they were excluded from clinical trials.
      • Craig A.M.
      • Hughes B.L.
      • Swamy G.K.
      • et al.
      Coronavirus disease 2019 vaccines in pregnancy.
      Therefore, in the absence of sufficient results and the lack of evidence for the safe use of corona virus vaccines by this population, it was important to assess and describe the perceptions of these women regarding vaccination in order to inform decision makers about factors affecting adherence and reluctance to vaccination among this population. Hence, providing them with crucial information that can assist them further promote vaccination.
      This article is a cross-sectional study that aims at investigating the rate of vaccination among Moroccan mothers who gave birth in the last two years along with assessing their reasons for accepting or refusing vaccination, as well as to explore the determinants of reluctance or adherence to vaccination among this population, and to investigate the intention towards vaccination among the unvaccinated.

      2. Methods

      2.1 Study type and population

      This was a descriptive and cross-sectional study, conducted in the health centers of the Skhirat-Temara prefecture in Morocco among adult mothers who resided in the same prefecture and accompanied their children aged one to 24 months (who were born or were breastfed during the first three waves of the Covid-19 pandemic in Morocco) for vaccination or other care. The survey period was from October 2021 to January 2022.

      2.2 Eligibility criteria

      Only mothers aged 18 years and up and given consent to participate to the study were included. Those who refused to participate in the study were excluded.

      2.3 Questionnaire and sample

      The sample size required for the results of this survey to be representative was calculated using the following formula
      • Serhier Z.
      • Bendahhou K.
      • Ben Abdelaziz A.
      • Bennani M.O.
      • et al.
      Methodological sheet n°1: how to calculate the size of a sample for an observational study?.
      :
      n=z²×p×(1p)m²=384.16385


      Where: n = sample size
      z = 1.96 for a 95% confidence level
      p = 0.5 (to our knowledge, no national study available to inform us on the prevalence of pregnant or lactating women vaccinated)
      m = 0.05 (margin of sampling error tolerated).
      However, our survey included 458 participants who completed a standardized questionnaire divided into two sections. The first section was used to provide information on demographics, socioeconomic and clinical characteristics (maternal age, marital status, education level, place of residence, maternal occupation, monthly household income, history of gestational diabetes, history of COVID-19, etc.), as well as the vaccination status of the participants during pregnancy and after delivery and the age of their last child. The second section provides information on perceptions and future intentions to adhere to vaccination among participants initially reported as unvaccinated.

      2.4 Statistical analysis

      Descriptive statistics and frequencies were computed for each variables of the questionnaire.
      Univariate analysis was performed using the Chi-square test and Fisher's exact test according to the test conditions. The logistic regression analysis was performed to assess the independent effect of age, residence, couple's education level, monthly household income, medical coverage, age of last child, history of COVID-19, and previous gestational diabetes on vaccination against COVID-19.
      The list of the explanatory variables was established according to the results of the univariate analysis. A difference was considered to be statistically significant if the p value was less than 0.05. The associations were expressed in odds ratio (OR) at a confidence interval of 95%. Data analysis was performed using the statistical software Jamovi 1.6.

      Ethics approval

      This study was conducted with the approval of the Ethics Committee for Biomedical Research, Faculty of Medicine and Pharmacy, Mohamed V University of Rabat, Morocco (ethical approval n° C68/20 issued on February 18, 2021).
      All the Participants were provided with a briefing note explaining the purpose of the study, the interview process, the confidentiality of the data, and the utility of the study results. Subsequently, oral and written informed consent was obtained from the participants before the interview began.

      3. Results

      3.1 Characteristics of the participants

      The results of the feature analysis are presented in Table 1. Our survey included 458 participants who accompanied their children aged 1–24 months to health centers in the Skhirat-Temara prefecture in Morocco for vaccination or other outpatient care. More than half of the respondents were between 18 and 29 years old (57.4%), the majority were married (98.9%), and 54.4% had children between 1 and 6 months old. A large percentage (92.6%) lived in urban areas. Primary education was the dominant level of education for the participants and their spouses (48.9% and 49.6% respectively). Around 85.8% of the respondents were not in the workforce while almost all (99.1%) of the spouses were gainfully employed. For more than 40% of the participants, their monthly household income was less than $282 (the monthly household income was defined in terms of the Moroccan Guaranteed Minimum Interprofessional Income set at ≈ 2800 Moroccan dirham ≈ $282) while 12.9% had no medical coverage. For participants' clinical history during the pandemic, 10.7% had COVID-19, and 11.8% had gestational diabetes.
      Table 1Description of the main features of the population of the study (n = 458).
      Frequency (%)
      Age group of participants18–29 years old263 (57.4)
      30–40 years old178 (38.9)
      More than 40 years old17 (3.7)
      Marital statusMarried453 (98.9)
      Not married5 (1.1)
      ResidenceUrban424 (92.6)
      Rural34 (7.4)
      Mother's education levelIlliterate73 (15.9)
      Primary224 (48.9)
      Secondary79 (17.2)
      Higher82 (17.9)
      Father's education levelIlliterate62 (13.5)
      Primary227 (49.6)
      Secondary98 (21.4)
      Higher71 (15.5)
      Mother's workYes65 (14.2)
      No393 (85.8)
      Spouse's workYes454 (99.1)
      No4 (0.9)
      Monthly household income<$282185 (40.3)
      $282 – $504183 (40)
      More than $50490 (19.7)
      Medical coverageYes399 (87.1)
      No59 (12.9)
      Age of the last child≤6 months249 (54.4)
      7–12 months106 (23.1)
      More than 12 months103 (22.5)
      Previous gestational diabetesYes54 (11.8)
      No404 (88.2)
      Previous COVID-19Yes49 (10.7)
      No409 (89.3)

      3.2 Prevalence of vaccine acceptance

      As far as vaccination status is concerned, almost two thirds of the participants (61.8%) had received at least one dose of the COVID- 19 vaccine; however, none of the vaccinated women had been vaccinated during their pregnancy (Fig. 1).
      Fig. 1
      Fig. 1The prevalence and period of vaccination against covid-19 among the participant group.

      3.3 Intent of the unvaccinated on further vaccination

      Concerning the response to the intention to be vaccinated against COVID-19 among the unvaccinated (38.2%), Fig. 2 reveals that 64% expressed their willingness to vaccination either because they were convinced of the importance of vaccination to face the pandemic (52.6%) or to obtain the vaccine pass (47.3%). On the other hand, 36% of the participants did not intend to be vaccinated and the major perception (60.3%) was the lack of information about the efficacy and safety of the new vaccines against COVID-19.
      Fig. 2
      Fig. 2Perceptions of unvaccinated regarding intention to be vaccinated against COVID-19 in the future.

      3.4 Univariate and multivariate analysis of participants' characteristics towards vaccination

      The association study between acceptance of COVID-19 vaccination and participant characteristics reveals that the place of residence, couple's education level, monthly household income, history of gestational diabetes, and age of last child were significantly associated with acceptance of vaccination (Table 2). All variables with a p-value of less than 25% were included in the multivariate analysis.
      Table 2Univariate and multivariate analysis of participants' characteristics by vaccination status (n = 458).
      CharacteristicsUnivariate analysisMultivariate analysis
      Vaccination statusaOR*IC 95%p
      YesNop
      n (%)n (%)
      Age group of participants
      18–29 years old163 (57.6)100 (57.1)1
      30–40 years old109 (38.5)69 (39.4)0.9570.950.61–1.490.95
      More than 40 years old11 (3.9)6 (3.4)0.840.25–2.77
      Marital status
      Married279 (98.6)174 (99.4)0.654
      Fisher's exact test. A p value < 0.05 is considered significant. *aOR: Adjusted odds ratio.
      Not married4 (1.4)1 (0.6)
      Residence
      Urban256 (90.5)168 (96)0.028
      Rural27 (9.5)7 (4)
      Mother's education level
      Illiterate49 (17.3)24 (13.7)
      Primary145 (51.2)79 (45.1)0.008
      Secondary52 (18.4)27 (15.4)
      Higher37 (13.1)45 (25.7)
      Father's education level
      Illiterate48 (17)14 (8)
      Primary143 (50.5)84 (48)0.012
      Secondary51 (18)47 (26.9)
      Higher41 (14.5)30 (17.1)
      Mother's work
      Yes42 (14.8)23 (13.1)0.613
      No241 (85.2)152 (86.9)
      Spouse's work
      Yes282 (99.6)172 (98.3)0.158
      Fisher's exact test. A p value < 0.05 is considered significant. *aOR: Adjusted odds ratio.
      No1 (0.4)3 (1.7)
      Monthly household income
      <$282130 (45.9)55 (31.4)1
      $282– $504103 (36.4)80 (45.7)0.0090.470.28–0.760.003
      More than $50450 (17.7)40 (22.9)0.440.25–0.80
      Medical coverage
      Yes252 (89)147 (84)0.1171
      No31 (11)28 (16)0.520.27–0.980.046
      Age of the last child
      ≤6 months108 (38.2)141 (80.6)1
      7–12 months87 (30.7)19 (10.9)<0.0015.853.30–10.36<0.001
      More than 12 months88 (31.1)15 (8.6)8.624.62–16.08
      CharacteristicsUnivariate analysisMultivariate analysis
      Vaccination statuspaOR*IC 95%p
      YesNo
      n (%)n (%)
      Previous gestational diabetes
      Yes24 (8.5)30 (17.1)1
      No259 (91.5)145 (82.9)0.0052.281.17–4.470.016
      Previous COVID-19
      Yes34 (12)15 (8.6)0.247
      No249 (88)160 (91.4)
      a Fisher's exact test. A p value < 0.05 is considered significant. *aOR: Adjusted odds ratio.
      Subsequently, the multivariate analysis showed that having a monthly income higher than $282 significantly decreases the chance of accepting vaccination compared to those who had an income lower than $282. In addition, not having medical coverage decreased the chance of being vaccinated to 48% compared to those who had it (aOR = 0.52, 95% CI: 0.27–0.98; p = 0.046). Finally, not having gestational diabetes in the last pregnancy increased the chance of being vaccinated by more than two times compared to those who did. In addition, the age of the last child was a very significant determinant to influence the practice of vaccination among the participants (p < 0.001).

      4. Discussion

      This current cross-sectional study aims at investigating women's practices and perceptions of COVID-19 vaccination during pregnancy and postpartum (up to 24 months), as well as assessing the predictive determinants of acceptance of vaccination.
      In this study, all participants revealed that they avoided being vaccinated during their pregnancies even with the availability of the vaccines and the recommendations of the national scientific commission, which are in line with those of the international learned society in favor of vaccination of pregnant and breastfeeding women.
      • Rasmussen S.A.
      • Jamieson D.J.
      • et al.
      Pregnancy, postpartum care, and COVID-19 vaccination in 2021.
      ,
      • Davanzo R.
      • et al.
      Breastfeeding and COVID-19 vaccination: position statement of the Italian scientific societies.
      This result was nil compared to those reported in studies conducted in United States, and the Saudi Arabia, where the prevalence rates of vaccination among pregnant women were 29.3%, 32.0% respectively.
      • Binger K.S.
      • Cui Y.
      • Tsaih S.-W.
      • Palatnik A.
      • et al.
      Factors associated with receipt of COVID-19 immunization during pregnancy.
      ,
      • Ghamri R.A.
      • Othman S.S.
      • Alhiniah M.H.
      • Alelyani R.H.
      • Badawi A.M.
      • Alshahrani A.A.
      • et al.
      Acceptance of COVID-19 vaccine and associated factors among pregnant women in Saudi Arabia.
      This attitude can be explained by women's sense of responsibility to protect the health of their fetuses and newborns during pregnancy and breastfeeding in the absence of evidence of the safety of the new, rapidly developed vaccines such as those against COVID-19.
      • Wilson R.J.
      • Paterson P.
      • Jarrett C.
      • Larson H.J.
      • et al.
      Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review.
      Therefore, the risk of harming children's health during pregnancy and breastfeeding, and the lack of reliable data on vaccination of this vulnerable segment of the population are considered determinants of non-adherence to COVID-19 vaccination. In contrast, the vaccination prevalence rate among participants who received at least the first dose during the survey period was 61.8%.
      Concerning the perceptions of the unvaccinated regarding intention to be vaccinated against COVID-19 in the future, when the unvaccinated (175 participants) were asked if they would be willing to be vaccinated, the results showed that 64% of them expressed willingness to be vaccinated. In comparison with other studies, this result was almost similar in six European countries where 60–70% of pregnant and lactating women expressed willingness to be vaccinated.
      • Ceulemans M.
      • et al.
      Vaccine willingness and impact of the COVID-19 pandemic on women's perinatal experiences and practices—a multinational, cross-sectional study covering the first wave of the pandemic.
      However, nearly half of the participants who changed their minds about vaccination (47.3%) made that choice just to have the vaccination pass required by the public authorities to be able to carry out normal activities of daily life. Vaccine pass possession can be included in the Compliance component, which is one of the most significant determinants of psychological readiness for vaccination acceptance.

      M. Geiger et al., « Measuring the 7Cs of vaccination readiness. », Eur J Psychol Assess, 20210715, doi: 10.1027/1015-5759/a000663.

      Indeed, our finding is consistent with other studies that have indicated that vaccination can be accepted when it is considered a requirement to get free movement and access to public facilities and spaces.
      • Moccia G.
      • Carpinelli L.
      • Savarese G.
      • De Caro F.
      • et al.
      Vaccine hesitancy and the green digital pass: a study on adherence to the Italian COVID-19 vaccination campaign.
      Lastly, although two thirds of the unvaccinated (60.3%) who confirmed their categorical refusal of vaccination justified this behavior by the lack of information on the safety and security of vaccines against COVID-19, this result is considered lower than that reported in the Czech Republic (82.4%).
      • Riad A.
      • et al.
      COVID-19 vaccine acceptance of pregnant and lactating women (PLW) in Czechia: an analytical cross-sectional study.
      The result of the univariate analysis showed a significant association between adherence to vaccination and place of Residence, education level of the couples, previous history of gestational diabetes, monthly household income of the participants, and age of their last child. This association was consistent with the results of other studies.
      • Mose A.
      Willingness to receive COVID-19 vaccine and its determinant factors among lactating mothers in Ethiopia: a cross-sectional study.
      ,
      • Skirrow H.
      • et al.
      Women's views on accepting COVID-19 vaccination during and after pregnancy, and for their babies: a multi-methods study in the UK.
      However, there are other studies that have invalidated this association with antecedent gestational diabetes.

      M. K. Kiefer et al., « Characteristics and perceptions associated with COVID-19 vaccination hesitancy among pregnant and postpartum individuals: a cross-sectional study », BJOG An Int J Obstet Gynaecol, vol. n/a, no n/a, doi: 10.1111/1471-0528.17110.

      An odds ratio (OR) greater than 1 indicates positive adherence to vaccination, while an odds ratio less than 1 indicates the opposite attitude towards vaccination acceptance.
      In the multivariate analysis, the predictive determinants for low adherence to vaccination were monthly household income above $282 (middle or high income) and lack of medical coverage. This result was in line with the results of other studies that have confirmed our findings regarding the lack of medical coverage

      C. Nicastri et al., P. Kumar, « Psychosocial, economic, and mental health predictors of COVID-19 vaccine intent ». PsyArXiv, 10 février 2022. doi: 10.31234/osf.io/snrgf.

      • Ku L.
      The association of social factors and health insurance coverage with COVID-19 vaccinations and hesitancy, july 2021.
      • Callaghan T.
      • et al.
      « Correlates and Disparities of COVID-19 Vaccine Hesitancy », Social Science Research Network.
      as one of the limiting factors for adherence to COVID-19 vaccination.
      Nevertheless, this finding was found to be inconsistent with the results of other studies
      • Skirrow H.
      • et al.
      Women's views on accepting COVID-19 vaccination during and after pregnancy, and for their babies: a multi-methods study in the UK.
      ,
      • Ruiz J.B.
      • Bell R.A.
      • et al.
      Predictors of intention to vaccinate against COVID-19: results of a nationwide survey.
      which have reported that participants with average or high monthly incomes are more likely to accept vaccination than those with low incomes. Similarly, our result was opposed to that of Miranda K. Kiefer,

      M. K. Kiefer et al., « Characteristics and perceptions associated with COVID-19 vaccination hesitancy among pregnant and postpartum individuals: a cross-sectional study », BJOG An Int J Obstet Gynaecol, vol. n/a, no n/a, doi: 10.1111/1471-0528.17110.

      who found that having medical coverage was one of the factors for hesitancy and refusal of vaccination.
      On the other hand, having a child older than 6 months and not having gestational diabetes were considered positive factors for adherence to vaccination. This result may be explained by the reduced sense of risk to their children's health that mothers may feel as their children advance in age and do not rely solely on breastfeeding for nutrition, and as they develop immunity to disease as they grow older.
      In our study, women who had gestational diabetes were the least likely to adhere to vaccination compared to those who did not. This finding contradicts other study that found that participants who had gestational diabetes were the most accepting of the vaccination.
      • Ghamri R.A.
      • Othman S.S.
      • Alhiniah M.H.
      • Alelyani R.H.
      • Badawi A.M.
      • Alshahrani A.A.
      • et al.
      Acceptance of COVID-19 vaccine and associated factors among pregnant women in Saudi Arabia.
      This attitude can be related to the fear of worsening their clinical condition during pregnancy due to lack of awareness or information. Nevertheless, studies have shown that gestational diabetes increases the risk of getting COVID-19 and that vaccination against COVID-19 has been shown to have no adverse effect on ongoing pregnancy.
      • Perreand E.
      • et al.
      Gestational diabetes mellitus: a risk factor for COVID-19.
      ,
      • Dick A.
      • Rosenbloom J.I.
      • Gutman-Ido E.
      • Lessans N.
      • Cahen-Peretz A.
      • Chill H.H.
      • et al.
      Safety of SARS-CoV-2 vaccination during pregnancy- obstetric outcomes from a large cohort study.
      This study allowed us to make an initial diagnosis of the status of vaccination against COVID-19 among pregnant women and women with infants in Morocco, to reveal that adherence to vaccination was largely associated with the vaccination pass required by the authorities, while refusal was overwhelmingly justified by the lack of reliable data on vaccine safety and efficacy. In addition, factors such as income, medical coverage, history of gestational diabetes, and age of last child emerged as determinants of vaccine adherence.

      4.1 Limitation of the study

      Our study faced some limits. First, because of the fact that only few studies have reported the prevalence of effective vaccination among pregnant and lactating women, or those whose last delivery was less than two years ago, the results of univariate and multivariate analyses were compared with studies exploring the intention to vaccinate in that particular population. Participants with a positive attitude towards vaccination were considered as if they were vaccinated, and those with a negative attitude were considered as if they were unvaccinated. Secondly, the cross-sectional study we conducted does not allow us to establish cause-effect relationship.

      5. Conclusion

      In conclusion, the results of this study can serve as a roadmap for policymakers and public health officials to better inform and educate pregnant and lactating women about the safety and efficacy of available vaccines, as well as to address factors that may discourage this population from getting vaccinated.

      Data availability

      All data relevant to the study is reported in the article, the author is welcome to provide further information or clarification.

      Declaration of competing interest

      The authors declare that they have no conflicts of interest.

      Acknowledgments and funding

      The authors would like to thank all those who contributed to this article.

      References

        • Chakraborty C.
        • Sharma A.R.
        • Bhattacharya M.
        • Lee S.-S.
        • Agoramoorthy G.
        • et al.
        COVID-19 vaccine: challenges in developing countries and India's initiatives.
        Inf Med. 2021; 29 (01): 165-166
        • Al-Qerem W.A.
        • Jarab A.S.
        • et al.
        COVID-19 vaccination acceptance and its associated factors among a middle eastern population.
        Front Public Health. 2021; 9 (Consulté le: 12 avril 2022. [En ligne]. Disponible sur:)
        • Sallam M.
        COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates.
        Vaccines. 2021; 9 (Art. no 2, févr)https://doi.org/10.3390/vaccines9020160
      1. OPSFPLIMCOVID-19210008_fre.pdf ». Consulté le: 12 avril 2022. [En ligne]. Disponible sur.
        • Garg I.
        • Shekhar R.
        • Sheikh A.B.
        • Pal S.
        • et al.
        COVID-19 vaccine in pregnant and lactating women: a review of existing evidence and practice guidelines.
        Infect Dis Rep. 2021; 13 (Art. no 3, sept)https://doi.org/10.3390/idr13030064
        • Craig A.M.
        • Hughes B.L.
        • Swamy G.K.
        • et al.
        Coronavirus disease 2019 vaccines in pregnancy.
        Am J Obstetric Gynecol MFM. 2021; 3 (mars)100295https://doi.org/10.1016/j.ajogmf.2020.100295
        • Serhier Z.
        • Bendahhou K.
        • Ben Abdelaziz A.
        • Bennani M.O.
        • et al.
        Methodological sheet n°1: how to calculate the size of a sample for an observational study?.
        Tunis Med. 2020; 98 (janv): 1-7
        • Rasmussen S.A.
        • Jamieson D.J.
        • et al.
        Pregnancy, postpartum care, and COVID-19 vaccination in 2021.
        JAMA. 2021; 325 (mars): 1099-1100https://doi.org/10.1001/jama.2021.1683
        • Davanzo R.
        • et al.
        Breastfeeding and COVID-19 vaccination: position statement of the Italian scientific societies.
        Ital J Pediatr. 2021; 47 (févr): 45https://doi.org/10.1186/s13052-021-00998-6
        • Binger K.S.
        • Cui Y.
        • Tsaih S.-W.
        • Palatnik A.
        • et al.
        Factors associated with receipt of COVID-19 immunization during pregnancy.
        Am J Obstet Gynecol. 2022; 226 (janv): S497-S498https://doi.org/10.1016/j.ajog.2021.11.823
        • Ghamri R.A.
        • Othman S.S.
        • Alhiniah M.H.
        • Alelyani R.H.
        • Badawi A.M.
        • Alshahrani A.A.
        • et al.
        Acceptance of COVID-19 vaccine and associated factors among pregnant women in Saudi Arabia.
        Patient Prefer Adherence. 2022; 16 (avr): 861-873https://doi.org/10.2147/PPA.S357653
        • Wilson R.J.
        • Paterson P.
        • Jarrett C.
        • Larson H.J.
        • et al.
        Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review.
        Vaccine. 2015; 33 (nov): 6420-6429https://doi.org/10.1016/j.vaccine.2015.08.046
        • Ceulemans M.
        • et al.
        Vaccine willingness and impact of the COVID-19 pandemic on women's perinatal experiences and practices—a multinational, cross-sectional study covering the first wave of the pandemic.
        Int J Environ Res Publ Health. 2021; 18 (Art. no 7, janv)https://doi.org/10.3390/ijerph18073367
      2. M. Geiger et al., « Measuring the 7Cs of vaccination readiness. », Eur J Psychol Assess, 20210715, doi: 10.1027/1015-5759/a000663.

        • Moccia G.
        • Carpinelli L.
        • Savarese G.
        • De Caro F.
        • et al.
        Vaccine hesitancy and the green digital pass: a study on adherence to the Italian COVID-19 vaccination campaign.
        Int J Environ Res Publ Health. 2022; 19 (Art. no 5, janv)https://doi.org/10.3390/ijerph19052970
        • Riad A.
        • et al.
        COVID-19 vaccine acceptance of pregnant and lactating women (PLW) in Czechia: an analytical cross-sectional study.
        Int J Environ Res Publ Health. 2021; 18 (Art. no 24, janv)https://doi.org/10.3390/ijerph182413373
        • Mose A.
        Willingness to receive COVID-19 vaccine and its determinant factors among lactating mothers in Ethiopia: a cross-sectional study.
        Infect Drug Resist. 2021; 14 (oct): 4249-4259https://doi.org/10.2147/IDR.S336486
        • Skirrow H.
        • et al.
        Women's views on accepting COVID-19 vaccination during and after pregnancy, and for their babies: a multi-methods study in the UK.
        BMC Pregnancy Childbirth. 2022; 22 (janv): 33https://doi.org/10.1186/s12884-021-04321-3
      3. M. K. Kiefer et al., « Characteristics and perceptions associated with COVID-19 vaccination hesitancy among pregnant and postpartum individuals: a cross-sectional study », BJOG An Int J Obstet Gynaecol, vol. n/a, no n/a, doi: 10.1111/1471-0528.17110.

      4. C. Nicastri et al., P. Kumar, « Psychosocial, economic, and mental health predictors of COVID-19 vaccine intent ». PsyArXiv, 10 février 2022. doi: 10.31234/osf.io/snrgf.

        • Ku L.
        The association of social factors and health insurance coverage with COVID-19 vaccinations and hesitancy, july 2021.
        J Gen Intern Med. 2022; 37 (févr): 409-414https://doi.org/10.1007/s11606-021-07213-6
        • Callaghan T.
        • et al.
        « Correlates and Disparities of COVID-19 Vaccine Hesitancy », Social Science Research Network.
        2020https://doi.org/10.2139/ssrn.3667971 (Rochester, NY, SSRN Scholarly Paper 3667971, août)
        • Ruiz J.B.
        • Bell R.A.
        • et al.
        Predictors of intention to vaccinate against COVID-19: results of a nationwide survey.
        Vaccine. 2021; 39 (févr): 1080-1086https://doi.org/10.1016/j.vaccine.2021.01.010
        • Perreand E.
        • et al.
        Gestational diabetes mellitus: a risk factor for COVID-19.
        Am J Obstet Gynecol. 2022; 226: S750-S751
        • Dick A.
        • Rosenbloom J.I.
        • Gutman-Ido E.
        • Lessans N.
        • Cahen-Peretz A.
        • Chill H.H.
        • et al.
        Safety of SARS-CoV-2 vaccination during pregnancy- obstetric outcomes from a large cohort study.
        BMC Pregnancy Childbirth. 2022; 22 (févr): 166https://doi.org/10.1186/s12884-022-04505-5